Merck did not issue a release or note the FDA’s reasoning behind the rejection, but included a brief mention in the company’s regulatory filing with the Securities and Exchange Commission, the report said,
Related Articles on Ophthalmology:
Study: Patients With Glaucoma Vision Loss Have Higher Fall Risk
Ophthalmologist on the Move: Dr. Rodney P. Coe Joins the Retina Group of New York
10 Points on Ophthalmology in Surgery Centers
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
